.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Plenary hall

06.12.2023

10:45 – 11:45
Plenary session
PS 1
PS 1 | Medication overuse: A new story?
Plenary hall
12:00 – 13:00
Plenary session
PS 2
PS 2 | Dizziness in migraine and pathophysiology of vestibular migraine
Plenary hall
13:30 – 14:30
Industry session
SpSy
Sponsored symposium 1
Plenary hall
14:40 – 15:55
Plenary session
PS 3
PS 3 & Opening | Role of the calvarium, brain immune barriers and fluid transport
Plenary hall
16:15 – 17:15
Industry session
SpSy
Sponsored symposium 2
Plenary hall
17:30 – 19:00
Scientific session
ScS 1
ScS 1 | CSF dynamics and headache disorders
Plenary hall

07.12.2023

08:30 – 09:30
Plenary session
PS 4
PS 4 | Headache therapy
Plenary hall
09:45 – 11:15
Scientific session
ScS 3
ScS 3 | Aura and premonitory symptoms
Plenary hall
11:45 – 12:45
Industry session
SpoSy
Sponsored symposium 3
Plenary hall
13:00 – 13:30
Update session
UpS 1
UpS 1 | SAS-Session: EHF School of Advanced Studies
Plenary hall
14:00 – 15:15
Debate session
DS 1
DS 1 | The EHF debate on acute migraine medication
Plenary hall
15:45 – 16:30
Plenary session
PS
Special session | Lifetime achievement & Greppi award
Plenary hall
16:45 – 18:15
Scientific session
ScS 5
ScS 5 | The non-responders: It is not all about CGRP
Plenary hall

08.12.2023

08:00 – 08:30
Update session
UpS 2
UpS 2 | Update in genetics and others
Plenary hall
08:30 – 09:30
Debate session
DS 2
DS 2 | Epidemiology: Migraine is more frequent in women – myth or fact?
Plenary hall
09:45 – 11:15
Scientific session
ScS 7
ScS 7 | Cognitive dysfunction in migraine: Myth or reality?
Plenary hall
11:45 – 12:45
Industry session
SpoSy
Sponsored symposium 5
Plenary hall
13:00 – 14:00
Debate session
DS 3
DS 3 | Devices and non-pharmacological therapies
Plenary hall
14:15 – 15:15
Scientific session
ScS 10
ScS 10 | New treatments in childhood headache
Plenary hall
15:45 – 16:45
Industry session
SpSy
Sponsored symposium 6
Plenary hall
17:00 – 18:30
Scientific session
ScS 11
ScS 11 | Burden of headaches
Plenary hall

09.12.2023

08:00 – 08:30
Update session
UpS 3
UpS 3 | Update in facial pain
Plenary hall
08:30 – 09:30
Plenary session
PS 5
PS 5 | Trial designs that lead to medication availability in Europe
Plenary hall
09:45 – 11:15
Scientific session
ScS 13
ScS 13 | Cardiovascular risk factors in women
Plenary hall
11:30 – 12:30
Plenary session
PS 6
PS 6 | Envisioning reaching SDG3 through headache prevention, prediction, detection, response
Plenary hall
12:30 – 13:00
Plenary session
PS
Closing & award ceremony
Plenary hall